Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 75Genitourinary 13Sarcoma 11Gynecologic 11Head & Neck 8CNS 4Other hematologic neoplasm 3Gastrointestinal 3Dermatologic 3Breast 3Tumor-Agnostic 2Thoracic 1Plasma cell 1

Conditions

Skin Neoplasms 2Melanoma 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Bleomycin × Dermatologic × Clear all
NCT06647342 2025-01-23

BLESS

Zealand University Hospital

Phase 4 Recruiting
55 enrolled
Dermatologic

Skin Neoplasms

NCT00993512 2019-04-29

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

PCI Biotech AS

Phase 1 Completed
19 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Skin Neoplasms

NCT00006035 2013-09-17

Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1 Unknown
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡